Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerance induction through early feeding to prevent food allergy in infants with eczema (TEFFA): rationale, study design, and methods of a randomized controlled trial.
Kalb B, Meixner L, Trendelenburg V, Unterleider N, Dobbertin-Welsch J, Heller S, Dölle-Bierke S, Roll S, Lau S, Lee YA, Fauchère F, Braun J, Babina M, Altrichter S, Birkner T, Worm M, Beyer K. Kalb B, et al. Among authors: meixner l. Trials. 2022 Mar 12;23(1):210. doi: 10.1186/s13063-022-06126-x. Trials. 2022. PMID: 35279213 Free PMC article. Clinical Trial.
Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study.
Trendelenburg V, Dölle-Bierke S, Unterleider N, Alexiou A, Kalb B, Meixner L, Heller S, Lau S, Lee YA, Fauchère F, Braun J, Babina M, Altrichter S, Birkner T, Roll S, Dobbertin-Welsch J, Worm M, Beyer K. Trendelenburg V, et al. Among authors: meixner l. Trials. 2022 Mar 28;23(1):236. doi: 10.1186/s13063-022-06149-4. Trials. 2022. PMID: 35346330 Free PMC article. Clinical Trial.
Tolerance induction through early feeding to prevent food allergy in infants and children with sensitization against food allergens (TIFFANI): rationale, study design, and methods of a randomized controlled trial.
Kalb B, Meixner L, Heller S, Dölle-Bierke S, Roll S, Tissen-Diabaté T, Lau S, Forslund S, Marenholz I, Lee YA, Thiel A, Babina M, Scheffel J, Worm M, Beyer K. Kalb B, et al. Among authors: meixner l. Trials. 2024 Apr 19;25(1):272. doi: 10.1186/s13063-024-08114-9. Trials. 2024. PMID: 38641837 Free PMC article. Clinical Trial.
Filaggrin loss-of-function mutations are associated with persistence of egg and milk allergy.
Kalb B, Marenholz I, Jeanrenaud ACSN, Meixner L, Arnau-Soler A, Rosillo-Salazar OD, Ghauri A, Cibin P, Blümchen K, Schlags R, Hansen G, Seidenberg J, Keil T, Lau S, Niggemann B, Beyer K, Lee YA. Kalb B, et al. Among authors: meixner l. J Allergy Clin Immunol. 2022 Nov;150(5):1125-1134. doi: 10.1016/j.jaci.2022.05.018. Epub 2022 Jun 15. J Allergy Clin Immunol. 2022. PMID: 35714843 Free article.
Twist1 induces distinct cell states depending on TGFBR1-activation.
Dragoi D, Krattenmacher A, Mishra VK, Schmidt JM, Kloos UJ, Meixner LK, Hauck SM, Buggenthin F, Schwartz D, Marr C, Johnsen SA, Scheel CH. Dragoi D, et al. Among authors: meixner lk. Oncotarget. 2016 May 24;7(21):30396-407. doi: 10.18632/oncotarget.8878. Oncotarget. 2016. PMID: 27105506 Free PMC article.
22 results